PPT-EMPA-REG Trial Randomised
Author : olivia-moreira | Published Date : 2020-01-30
EMPAREG Trial Randomised doubleblind placebocontrolled cardiovascular outcomes trial The primary end point is the time from randomization to a composite outcome
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "EMPA-REG Trial Randomised" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
EMPA-REG Trial Randomised: Transcript
EMPAREG Trial Randomised doubleblind placebocontrolled cardiovascular outcomes trial The primary end point is the time from randomization to a composite outcome consisting of the first occurrence of cardiovascular death nonfatal myocardial infarction or nonfatal stroke 3 point Major Adverse Cardiovascular Events or 3MACE. Asp irin and ticlopidine have been shown to be effective but both have potentially serious adverse effects Clopidogrel a new thienopyridine derivative similar to ticlopidine is an inhibitor of platelet aggregation induced by adenosine diphosphate Me Barrister–At-Law. 1. ENFORCEMENT OF EU ENVIRONMENTAL LAW . Introduction. 2. Effective enforcement of EU environmental law in Ireland a persistent multidimensional problem . Key problem is with access to courts to secure enforcement of EU environmental law with the costs of legal proceedings a particular issue. . to increase smoking cessation by maintaining NHS Stop Smoking Service attendance FAITH MATCHAM PHD STUDENT, DEPARTMENT OF PSYCHOLOGICAL MEDICINE, IOPPN Today ◦ BACKGROUND ◦ AIM % Graeme MacLennan. James Lind. Born Edinburgh 1716. On HMS Salisbury in 1747 he allocated 12 men with scurvy. Cider. Seawater. Horseradish, mustard, garlic. Nutmeg. Elixir Vitriol . Oranges and Limes . Appraisal. “Frequency and Prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial”. Group. . 8. Case Illustration. A Couple, Men . and women . , 55 yo want to travel with economy . Program Overview. EMPA-REG OUTCOME: Trial Design. EMPA-REG OUTCOME: Primary Endpoint: 3-Point MACE*. EMPA-REG OUTCOME: CV Death . EMPA-REG OUTCOME: CV Death, . Nonfatal MI, and Nonfatal Stroke . EMPA-REG OUTCOME: . Randomised trials face many challenges including slow or suboptimal recruitment;. Across trials, it is estimated that less than 50% meet their recruitment target or do so only with an extension to the original trial duration;. for asymptomatic severe carotid artery stenosis. . Alison Halliday. Nuffield Department of Population Health (NDPH). University of Oxford, UK . for the ACST-2 collaborators. ACST-2. is published online in . open . label trial to determine the . cl. inical and . cost-. e. ffectiveness . of hypertonic saline (HTS 6%) and carbocisteine for . a. irway clea. r. ance versus usual care over 52 weeks in bronchiectasis (BE). V4.1 25.06.2020. Issue. Clinical course / prognosis varies ++. between Crohn’s patients. Often greater impact on patients’ . lives than the . diagnosis. of CD itself. Jess et al IBD 2007. Solberg et al. . 1. Queiroz LP, Peres MF, Piovesan EJ et al. . A nationwide population-based study of migraine in Brazil. . Cephalalgia. 2009;29(6):642-9.. 2. Queiroz LP, Silva Junior AA. . The prevalence and impact of headache in Brazi. . retrieval. for . the airborne APEX imaging . spectrometer. 7. th. DOAS Workshop, 6-8 July 2015 . Gerrit Kuhlmann. 1. , Andreas Hueni. 2. , Alexander Damm. 2. and Dominik Brunner. 1. 1. . Empa. , Swiss Federal Laboratories for Materials Science and Technology, Switzerland. testing an intervention . to. lower cardiovascular . disease risk for people with severe mental illnesses in primary . care. Alexandra Burton. Programme Manager. UCL Division of Psychiatry. Background . CONn. Syndrome screening and Evaluation in Primary care (CONSEP). Local presenter information. What is CONSEP?. CONSEP aims to increase screening and diagnosis of primary aldosteronism in people living with hypertension who attend general practice..
Download Document
Here is the link to download the presentation.
"EMPA-REG Trial Randomised"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents